The core competencies of Nanotherapeutics are development and cGMP manufacture of preclinical and clinical stage biopharmaceutical products. We have considerable expertise in the application of traditional and proprietary delivery technologies to a range of compounds and materials for potential therapeutic benefit. Our business model is designed to exploit these capabilities through partnerships with government and established companies, as well as furthering our internal pipeline.
- We work with established companies and government programs to develop new products
- We develop our internal programs through to Phase 2/3
We develop and manufacture commercial products for our partners. In addition, we have been successful in obtaining non-dilutive government contracts and grants (over $500 million to date) for the advanced development and manufacturing of products. These funds have been used for preclinical to clinical development of multiple programs, which would otherwise require investor funds. In addition, these non-dilutive funds have allowed us to build our manufacturing and quality management systems infrastructure.
We invite conversations with interested parties to discuss their product development needs and our capabilities to meet those needs.